INTRODUCTION: There is a scarcity of research into the use of non-physician-sourced cross-sex hormones in the transgender population. However, when medication is not prescribed by health professionals, users' knowledge of such medication may be adversely affected. AIMS: This study aims to define the prevalence of Internet-sourced sex hormone use in a population attending for initial assessment at a gender identity clinic, to compare the prevalence between gender-dysphoric men and women, and to compare knowledge of cross-sex hormone side effects between users who source cross-sex hormones from medical doctors and those who source them elsewhere. METHODS: In the first part of the study, a cross-sectional design is used to measure the overall prevalence of sex hormone use among individuals referred to a gender clinic. The second part is a questionnaire survey aiming at measuring sex hormone knowledge among individuals referred to this clinic. MAIN OUTCOME MEASURES: Main outcome measures were (i) categorical data on the prevalence and source of cross-sex hormone use and (ii) knowledge of sex hormone side effects in a population referred to a gender clinic. RESULTS: Cross-sex hormone use was present in 23% of gender clinic referrals, of whom 70% sourced the hormones via the Internet. Trans men using testosterone had a sex hormone usage prevalence of 6%; one-third of users sourced it from the Internet. Trans women had a sex hormone usage prevalence of 32%; approximately 70% of users sourced hormones from the Internet. Cross-sex hormone users who sourced their hormones from physicians were more aware of side effects than those who used other sources to access hormones. CONCLUSION: One in four trans women self-prescribe cross-sex hormones before attending gender clinics, most commonly via the Internet. This practice is currently rare among trans men. Self-prescribing without medical advice leaves individuals without the knowledge required to minimize health risks.
INTRODUCTION: There is a scarcity of research into the use of non-physician-sourced cross-sex hormones in the transgender population. However, when medication is not prescribed by health professionals, users' knowledge of such medication may be adversely affected. AIMS: This study aims to define the prevalence of Internet-sourced sex hormone use in a population attending for initial assessment at a gender identity clinic, to compare the prevalence between gender-dysphoric men and women, and to compare knowledge of cross-sex hormone side effects between users who source cross-sex hormones from medical doctors and those who source them elsewhere. METHODS: In the first part of the study, a cross-sectional design is used to measure the overall prevalence of sex hormone use among individuals referred to a gender clinic. The second part is a questionnaire survey aiming at measuring sex hormone knowledge among individuals referred to this clinic. MAIN OUTCOME MEASURES: Main outcome measures were (i) categorical data on the prevalence and source of cross-sex hormone use and (ii) knowledge of sex hormone side effects in a population referred to a gender clinic. RESULTS: Cross-sex hormone use was present in 23% of gender clinic referrals, of whom 70% sourced the hormones via the Internet. Trans men using testosterone had a sex hormone usage prevalence of 6%; one-third of users sourced it from the Internet. Trans women had a sex hormone usage prevalence of 32%; approximately 70% of users sourced hormones from the Internet. Cross-sex hormone users who sourced their hormones from physicians were more aware of side effects than those who used other sources to access hormones. CONCLUSION: One in four trans women self-prescribe cross-sex hormones before attending gender clinics, most commonly via the Internet. This practice is currently rare among trans men. Self-prescribing without medical advice leaves individuals without the knowledge required to minimize health risks.
Authors: Max Lichtenstein; Laura Stein; Erin Connolly; Zil G Goldstein; Tyler Martinson; Linda Tiersten; Sangyoon J Shin; John Henry Pang; Joshua D Safer Journal: Transgend Health Date: 2020-09-02
Authors: Tiffany R Glynn; Kristi E Gamarel; Christopher W Kahler; Mariko Iwamoto; Don Operario; Tooru Nemoto Journal: Psychol Sex Orientat Gend Divers Date: 2016-04-28
Authors: Daphna Stroumsa; Halley P Crissman; Vanessa K Dalton; Giselle Kolenic; Caroline R Richardson Journal: Ann Fam Med Date: 2020-11 Impact factor: 5.166
Authors: Angelo Brandelli Costa; Heitor Tome da Rosa Filho; Paola Fagundes Pase; Anna Martha Vaitses Fontanari; Ramiro Figueiredo Catelan; Andressa Mueller; Dhiordan Cardoso; Bianca Soll; Karine Schwarz; Maiko Abel Schneider; Daniel Augusto Mori Gagliotti; Alexandre Saadeh; Maria Inês Rodrigues Lobato; Henrique Caetano Nardi; Silvia Helena Koller Journal: J Immigr Minor Health Date: 2018-02
Authors: Carly E Guss; David N Williams; Sari L Reisner; S Bryn Austin; Sabra L Katz-Wise Journal: J Adolesc Health Date: 2016-10-28 Impact factor: 5.012
Authors: Andrew M Busch; Mark E Louie; Nicholas J SantaBarbara; Alex A Ajayi; Neil Gleason; Shira I Dunsiger; Michael P Carey; Joseph T Ciccolo Journal: Ment Health Phys Act Date: 2019-09-12
Authors: Jamie Feldman; George R Brown; Madeline B Deutsch; Wylie Hembree; Walter Meyer; Heino F L Meyer-Bahlburg; Vin Tangpricha; Guy TʼSjoen; Joshua D Safer Journal: Curr Opin Endocrinol Diabetes Obes Date: 2016-04 Impact factor: 3.243